Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase 2 2Phase NA 1Phase 3 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Vomiting 2Neoplasms 1Nausea 1Lymphoma 1Hematologic Neoplasms 1

Interventions

Aprepitant 8Palonosetron 6Dexamethasone 6Granisetron 3fosaprepitant 2dexamethasone 21-phosphate 2Tropisetron 2Ondansetron 2Metoclopramide 2Calcium Dobesilate 2ramosetron 1naldemedine 1gamma-Aminobutyric Acid 1dolasetron 1dexamethasone acetate 1alizapride 1Tablets 1Spinal Puncture 1Saline Solution 1Population Groups 1Olanzapine 1Myelography 1Duration of Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Vomiting × Tropisetron × Clear all
NCT01636947 2018-09-25

KMEC

Merck Sharp & Dohme LLC

Phase 4 Completed
494 enrolled 14 charts

Nausea, Neoplasms, Vomiting

NCT02576327 2016-12-30

A Study Evaluating the Efficacy and Safety of Aprepitant in Autologous Hematopoietic Stem Cell Transplantation

Peking University

Phase 4 Unknown
130 enrolled
LymphoidOther hematologic neoplasm

Lymphoma, Vomiting, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡